Eaton Vance Management Integra Lifesciences Holdings Corp Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Eaton Vance Management holds 4,215,548 shares of IART stock, worth $123 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
4,215,548
Previous 4,226,696
0.26%
Holding current value
$123 Million
Previous $228 Million
21.81%
% of portfolio
0.26%
Previous 0.32%
Shares
22 transactions
Others Institutions Holding IART
# of Institutions
295Shares Held
69.9MCall Options Held
20.2KPut Options Held
9.3K-
Vanguard Group Inc Valley Forge, PA6.98MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$194 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.92MShares$172 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.91MShares$143 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.34MShares$97.3 Million0.02% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $2.43B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...